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INTRODUCTION 
Alzheimer’s disease (AD) is a progressive neurodegenera-
tive disease that is associated with global mental dysfunc-
tion and cognitive deterioration. Common pathological 
features of AD are the accumulation of intraneuronal tau 
and extracellular amyloid β (Aβ) peptide.[1] Accumulation 
of Aβ leads to the deposition of insoluble neuritic or senile 
plaques, thereby initiating a pathological cascade, which re-
sults in synaptic dysfunction, synaptic loss, neuronal death, 
and cognitive impairments.[2] Moreover, oxidative stress and 
inflammation are involved in Aβ-induced neuronal death 
and neurotransmitter deficits and the progression of AD.[3] 
Beta-amyloid (Aβ) protein plays a vital role in Alzheimer’s 
disease (AD). Although the mechanism of the disease is un-
known, the deleterious effect of beta-amyloid is quite clear. 
The protein self-aggregates into a plaque,[4] which leads 
to the generation of reactive oxygen species, membrane 
potential disruption and increased vulnerability to excite 
toxicity and cause eventually neuronal death[5] and related 
cognitive defects.[6] Recent report revealed an increasing 
prevalence of dementia worldwide, from 36 million in 2010 
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to 66 million by 2030, with the majority of AD.[7] Com-
plex pathology of AD, it is not very responsive to current 
modern medicines.[8,9]  Increasing research has turned to 
the traditional medicinal herbs, which are multitargeting, 
to search for a novel way of AD treatment.[10,11] Drosoph-
ila melanogaster developed as a model organism of drug 
screening neurodegenerative diseases. It possesses several 
unique features such as stable and fully known genetics, 
highly conserved disease pathways, high- throughput, and 
cost-effectiveness.[12] It was reported that many of the genes 
implicated in human AD pathogenesis have Drosophila 
homologs, including amyloid precursor protein (APP), 
γ-secretase, and tau.[13] But there are some dissimilarities, 
such as the absence of β-secretase, which causes a defect in 
endogenous production of Aβ42.
[14] In this investigation, the 
Drosophila models that overexpress human Aβ42 would be 
used. This model neurodegeneration would result in reduced 
lifespan, reduced locomotor activity, eye degeneration and 
histological change to the neuronal structure.[13,15] These 
pathological phenotypes could be observed within a few 
weeks, much faster than that of the counterpart phenotypes 
in transgenic mice.[16] Therefore, Drosophila as model of 
AD provides excellent tools for performing drug screens 
to identify drug candidates that can suppress the toxicity 
associated with Aβ accumulation. Medicinal plants are used 
to treat neurological disorders quite longer, for convulsion, 
stroke, and epilepsy, that is, Poriacocos, Polygala tenuifo-
lia, Uncariarhynchophylla, Ginkgo biloba, and Lycium bar-
barum.[11,17] Recent pharmacological studies revealed that 
Ginkgo biloba possessed neuroprotective effects towards 
D- galactose,[18] beta amyloid,[19] and ischemia-induced 
neuronal death.[20] Uncariarhynchophyllaalso prevented 
D-galactose,[21] beta-amyloid,[22] 6-hydroxydopamine,[23] 
and kainic acid-induced neurotoxicity.[24] In this study we 
selected a widely available plant Punicagranatum. L. var. 
Ganesh (Punicaceae), popularly known as pomegranate, 
madulai in Tamil, anar, dhalim in Hindi. P. granatumis 
a fruit-bearing deciduous shrub or small tree is widely 
cultivated throughout Asia and tropical Africa.[25] Some 
studies reported the bark, roots and leaves of the tree have 
antioxidant, anti-inflammatory, anti-carcinogenic medicinal 
benefits as well.[26-29] Unique tannins occur in pomegranate 
leaves, as well as in peel. Leaves of P. granatum also con-
tain glycosides of apigenin, a flavone with progestinic[30] 
and anxiolytic[31] properties. The fresh leaves extract of P. 
granatum has been found to be associated with free-rad-
ical scavenging activity.[32] Ellagic acid, another major 
ellagitannin present in the leaves, showed antioxidant and 
anti-inflammatory properties.[33,34] Apigenin, a flavone, and 
Punicalgin, anellagitanin, also present in the leaves of P. 
granatum have been known to exhibit anti-inflammatory 
actions.[25]
The bioactive products derived from plants are being 
considered to be an unparalleled source to design novel and 
effective therapeutic agents for the treatment of dreadful 
diseases, including cancer, cardiovascular and neural 
disorders.[35] Among the categories of natural products, 
triterpenoids represent a large family of compounds and 
comprise more than 20,000 identified terpenoids, including 
ursolic acid (UA) with promising remedial value.[36-38] 
UA is a pentacyclic triterpenoid compound that exists 
either as free acid or as aglycone of saponins. There has 
been extensive research to elucidate the UA-mediated 
pharmacological potential. It has been reported that UA 
can modulate a variety of signaling pathways associated 
with cancer survival and progression, cardiovascular and 
neural injuries.[36]
The survey of literature on P. granatumalso reveals 
that leaves contain various phytoconstituents like alkaloids, 
especially terpenoid compounds. The economic aspect 
of this crop evidently proved it as a commercial crop. 
Therefore research on the development of herbal products 
from this plant is required to be initiated immediately for 
exploring the unique potential of this crop which would 
also minimize the menacing wastage, especially the leaves. 
Therefore a well-coordinated effort by the farmers, traders, 
scientists, technologists, extension workers, physicians, 
administrators, and policymakers is required to be initiated 
to boost up the national economy as well as the proper 
exploitation of this for proper therapeutic purpose. Its 
traditional use in nervous disorders and the presence of a 
considerable quantity of extracts prompted us to investigate 
its protective effect on neurotoxicity in Drosophila model 
organism to develop the drug for neurodegeneration like 
AD.
MATERIALS AND METHODS
Donepezil, Drosophila food, analytical grade chloroform, 
ethanol. Aβ42 transgenic Drosophila melanogaster model 
was kindly provided by Prof. Dr. S.C. Lakhotia, Department 
of Zoology, Banarus Hindu University, Varanasi, India.
Collection And Authentication
The leaves of the healthy plant P.granatumselected for our 
study was collected from the Department of Horticulture, 
AC & RI, Tamilnadu Agricultural University, Madurai, 
Tamilnadu, India, during July 2016 and was authenticated 
by Dr. Stephen, Department of Botany, American college, 
Madurai.
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SEM Sample Preparation
Sample for SEM analysis were mounted on the specimen 
stub using carbon adhesive sheet. Small samples were 
mounted with I sq. cm glass slide and kept in carbon 
adhesive sheets. Samples were coated with gold to a 
thickness of 100 AO using Hitachi vacuum evaporator. 
The coated sample was analyzed in a Hitachi scanning 
electron microscope 3000 H model. Laboscope model 
Microscope with Photomicrograph and CCTV was 
used. 
Preparation of the Extracts From The Leaves
The leaves were dried at room temperature under a shade, 
powdered, sieved (60 mesh) and stored in a well-closed 
container. The dried leaf, CEPGL and ethanol (EEPGL) 
extracts were prepared using the rotary vacuum evaporator 
and analyzed by HPLC.
Identification of Compound Present in the Extracts of 
the Leaves by HPLC Analysis
Shimadzu BM-101 model used, Column: C-18 ODS, Mobile 
phase: ACN: Methanol 1:1, Flow rate: 0.5 mL/1 min, 
Injection volume: 20 µL, wavelength: 210 nm, standard 
ursolic acid 30.40 mg/100 mL.
Acute Toxicity Study Using Brine Shrimp 
(Artemianauplii) Lethality Bioassay (BSLA)
To study the toxicity of the extracts, we performed BSLA, 
which is based on the ability to kill laboratory cultured 
brine shrimp (Artemianauplii). The brine shrimp assay is a 
useful tool for preliminary assessment of toxicity, and it has 
been used for the detection of fungal toxins, plant extract 
toxicity, heavy metals, pesticides and cytotoxicity testing of 
dentalmaterials.[39,40]
Toxicity Assessment of CEPGL, EEPGL of the Leaf
Ten free-swimming hatched out Artemianauplli were 
drawn through a glass capillary and placed in each vial 
containing 4.5 mL of brine solution. In each experiment, 
0.5 mL brine solution containing various concentrations 
of extracts (ppm) were added to 4.5 mL of brine solution 
and maintained at room temperature for 24 hours under the 
light, then surviving larvae were counted. An experiment 
was conducted along with control (vehicle-treated), 
different concentrations of the extracts (100–2500 ppm) 
in a set of three tubes per dose. The percentage lethality 
was determined by comparing the mean surviving larval 
of the test and control tubes using Abbott’s formula. The 
graph plotted concentration verses percentage lethality. 
Podophyllotoxin was used as a positive control in the 
bioassay.
Culture of Drosophila Melanogaster
Flies were raised at 25°C on a standard corn meal medium 
supplemented with dry yeast.
In vivo Neuro Protective Activities of the CEPGL, 
EEPGL on A𝛽42 Expressing Drosophila  
melanogaster.[40,41]
Longivity Assay
Genetic crosses were performed in the vials containing the 
diet with treatments. The normal control, which did not 
express A𝛽42. The A𝛽42 expressing control (the positive 
control) was maintained on the normal diet. Standard drug 
treated group fed with diet containing 10 mmol donepezil/g 
of Drosophila media whereas the three CEPGL, EEPGL 
groups were fed with diets containing 1, 2, and 4 mg/g of 
Drosophila media, respectively. Newly hatched Drosophila 
in each group was transferred to a new vial (30 Drosophila 
per vial), continued with their respective treatments and 
incubated at 25°C. Dead Drosophila were counted on day 
1 and 5 in a 7-day cycle, and the remaining live Drosophila 
were transferred to a new vial containing the same diet. The 
feeding lasted for 65 days. 100 Drosophila were tested for 
eachgroup.
Climbing Assay
Locomotor function of Drosophila was measured by 
climbing assay. In brief, 30 Drosophila were placed at the 
bottom of a 15 mL falcon tube and were given 10 seconds 
to climb up the tube. At the end of each trial, the number of 
Drosophila that climbed up to a vertical distance of 8 cm or 
above was recorded. Drosophila was tested on days 1 and 
5 in a 7-day cycle. Each trial was performed three times. 
100 Drosophila were tested for eachgroup.
Pseudopupil Assay
The control and A𝛽42 Drosophila were treated with 
the same treatments as described above. Drosophila 
heads were examined under a light microscope. Briefly, 
5 days old Drosophila’s compound eye was viewed 
under a microscope in a dark field. There were eight 
photoreceptors in each ommatidium and seven of them 
were visible. Each photoreceptor projected a darkly 
staining rod, the rhabdomere, into the center of the 
ommatidium. The dissected heads with the neck were put 
on a slide. Shine light from the top through the compound 
eye. The rhabdomeres efficiently absorb light. Due to 
the retina’s precise architecture, the pictures of several 
ommatidia’s superposition appear as one pseudo pupil in 
the eye’s posterodorsal quadrant. Under the microscope, 
the rhabdomeres appeared as bright spots and rhabdomeres 
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in each ommatidium were counted. In the control group, 
seven rhabdomeres could be observed in each ommatidium. 
One hundred ommatidia were observed from 5 to 10 eyes, 
and the average rhabdomeres count per ommatidium was 
calculated. A total of 30 Drosophila were tested for each 
group in triplicate.
Nail Polish Imprint Technique41
In this technique, a nail polish (transparent) was used 
to create an exact replica of the eye’s external surface, 
which was then examined using a light microscope. An 
imprint of the fly’s adult eye was obtained by a small drop 
of transparent nail polish placed on the surface of a clean 
glass slide. The fly under examination was anesthetized, 
placed on a dry area of the slide and decapitated with a 
sharp blade or needle.
The head was held with forceps or needles and is 
dipped in the still fluid drop of nail polish. The head is 
then placed in a clean and dry area of the same slide, and 
the nail polish layer on the eyes is allowed to dry at room 
temperature (preferably 24°C) for 5 to 10 minutes. The 
dried layer of nail polish was easily peeled-off from the eye 
with the help of fine dissecting needles. The isolated peel, 
being a replica of the eye surface, assumes a goblet-shaped 
appearance. It was carefully placed on another clean glass 
slide with the imprint side facing upright. This imprint 
can be directly examined and photographed under a stereo 
binocular microscope to provide a low magnification image 
of the eye surface. For higher magnification and for a better 
image of the eye surface, the peel is carefully flattened by 
gently placing a coverslip over it and carefully applying 
slight pressure. The eye imprint is then examined under a 
microscope using a 10X or 45X differential interference 
contrast objective. The eye surface was observed under 
the SEM.
RESULTS
HPLC Profile of the CEPGL, EEPGL showed the presence 
of ursolic acid 20.34,0.1503%w/w respectively. In 
continuation of our efforts to verify the safety of extracts, we 
performed BSLA. It was observed that 100% of mortality 
for CEPGL, EEPGL was about 2500, 2000 ppm respectively 
in 24 hours.100% mortality was observed at 3ppm for 
podophyllotoxin positive control. These pre-screens showed 
safety of the CEPGL, EEPGL without any symptoms of 
toxicity (Graph.1).
In the present study neuroprotective effect was 
evaluated using Drosophila AD model. In the lifespan 
experiments, Aβ42 Drosophila showed a complete 
reduction in lifespan between 30-40 days when compared 
to control. CEPGL, EEPGL treatment significantly 
improved Drosophila dose’s survival dependently in the 
tested concentrations more than 40 days (p < 0.001). All 
treated groups showed significant improvement in survival. 
4mg/g showed maximum lifespan increase equivalent to the 
standard drug donepezil (Graph 2).
For locomotor abilities determination Aβ42 expressing 
Drosophila showed significantly impaired locomotion from 
the age of day 9 onwards. Extracts treated flies showed an 
improvement in locomotor activity dose-dependently. A 4 
mg/g concentration showed improvement in the locomotion 
equivalent to the standard drug donepezil (Graph 3).
In this study, the effect of Aβ42 expressing Drosophila 
on the degeneration of retinal tissue which was mainly 
neurons. Aβ42 expressing Drosophila contained significantly 
more degenerating rhabdomeres compared with the 
normal fly. The number of degenerated rhabdomeres was 
2 ± 0.258. The treated group has significantly rescued 
rhabdomeres in each ommatidium with an increased count 
of count, reflecting a preventive effect of the CEPGL, 
EEPGL on neurodegeneration (4.30 ± 0.223, 3.8 ± 0.20 
Graph.1:Acute Toxicity Study of CEPGL, EEPGL
Graph 2: Longivity Assay of CEPGL, EEPGL
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for 4 mg/g concentration respectively). This effect was 
comparable to the standard drug donepezil (Graph 4, 
Plate. 1-3).
Evaluation of Rhabdomeres Count
Evaluation of Surface Organization of OmmatidiaIn Adult 
Eyes By Nail – Polish Imprints and SEM.
Transgene expression in the eye cells severely disrupts 
the regular arrays of ommatidia due to neurodegeneration 
and its pattern was highly disorganized compared to the 
regular arrays of Ommatidia in the eyes of control flies. 
Interestingly, in most treated groups, the ommatidial 
organization and overall structure of the eye surface were 
significantly better, showing the restoration of ommatidial 
integrity and axons projecting from rhabdomeres to the 
optic lobe in the brain. CEPGL, EEPGL (4mg) treated 
Aβ42 transgenic fly ommatidia showed good surface 
improvement equivalent to donepezil treated by nail 
polish imprint method. The substantial improvements in 
the neurodegeneration phenotypes viz. eye morphology, 
formation, and rhabdomeres organization clearly showed 
that CEPGL, EEPGL suppresses neurodegeneration in fly 
models of AD toxicity. Surface morphology was observed 
under scanning electron microscope also to confirm the 
above findings. It can be concluded that CEPGL, EEPGL 
provides a balanced defense to neuronal cells against the 
toxic protein aggregates and their beneficial effects in 
suppressing inherited neurodegenerative disorders. Further 
investigation will help develop it as convenient therapeutic 
formulations for combating the increasing burden of 
neurodegenerative disorders.
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